주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
Updated : Friday, March 29, 2024, 22:07
Home
Login
Sign in
한국어
National
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
Macro-Economics
Trade
Foreign Exchanges
Industries
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
Company & Stock Tracking
Market Trend & Outlook
Finance
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
Science
New Tech
Blockchain
ESG
Environment
Social
Governance
Event
Exhibitions
Conferences
People
K-Culture
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
Editorials
Contributions
Who's Who
기사검색
검색
All articles
List
Subject Type
Summary Type
Photo Type
Humira Biosimilar Market About to Open in the U.S.
이미지기사
Lifestyle
Jung Suk-yee
2022.12.13 12:28
2023 NH Macro Strategy: Opportunities Arise from Embrace of Change
Finance
Lawrence Kim
2022.11.25 14:37
2023 Outlook: Bio: It’s Time for Biotech Firms to Outshine S&P500 Healthcare Players
Finance
Park Pyeong-kuk
2022.11.23 11:04
Celltrion Healthcare: Direct Sales to Begin in US
이미지기사
Finance
Park Pyeong-kuk
2022.11.14 13:12
SK Inc. Expanding into CGT CDMO Business
이미지기사
Industries
Jung Min-hee
2022.11.01 11:38
Celltrion at Odds with British Government over 'Penalizing Rebate'
이미지기사
Lifestyle
Choi Moon-hee
2022.10.27 10:50
Bio Industry: GPM Improvement of 10%p Key for Competitiveness in US Biosimilar Market
Finance
Park Pyeong-kuk
2022.10.14 14:40
SK Bioscience to Incorporate a Subsidiary in the U.S.
이미지기사
Lifestyle
Choi Moon-hee
2022.10.06 15:37
Data Released on Conglomerate Owner Families’ Stock-secured Loans
이미지기사
ESG
Yoon Young-sil
2022.09.28 12:11
Pharmaceutical/bio: Limited Impact Expected from US Biotech Executive Order
Finance
Lee Dong-gun & Won Jae-hee
2022.09.22 09:08
The U.S. Launches National Biotechnology and Biomanufacturing Initiative
이미지기사
Lifestyle
Choi Moon-hee
2022.09.14 11:11
Pharmaceutical/bio: Time for Momentum
Finance
Lee Dong-gun et al.
2022.09.07 09:01
Celltrion Healthcare: Prime Beneficiary of the Second Wave of Biosimilars
이미지기사
Finance
Kim Tae-hee
2022.08.31 09:22
Celltrion Healthcare: Conditions Met for a Virtuous Cycle Rally
이미지기사
Finance
Lee Dong-gun & Won Jae-hee
2022.08.18 11:55
Celltrion: Better Profitability, Increase in Remsima SC Market Share
이미지기사
Finance
Kim Tae-hee
2022.08.09 09:41
Celltrion: First Step toward a Virtuous Cycle Rally
이미지기사
Finance
Lee Dong-gun & Won Jae-hee
2022.08.09 09:35
Samsung Biologics: 2Q22 Review: Samsung Bioepis Fully Integrated
이미지기사
Finance
Park Pyeong-kuk
2022.08.01 09:00
Pharmaceutical/Bio: Brighter Days Ahead for Healthcare Stocks
Finance
Lee Dong-gun et al.
2022.07.04 09:53
Pharmaceutical/bio: Key Takeaways from EULAR 2022
Finance
Lee Dong-gun & Won Jae-hee
2022.06.10 13:53
Celltrion: Value of Remsima SC Reaffirmed at EULAR 2022
이미지기사
Finance
Kim Tae-hee
2022.06.08 09:35
처음
이전
이전
1
2
3
4
5
6
7
다음
다음
끝
위로
모바일버전
All articles
National
전체
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
전체
Macro-Economics
Trade
Foreign Exchanges
Industries
전체
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
전체
Company & Stock Tracking
Market Trend & Outlook
Finance
전체
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
전체
Science
New Tech
Blockchain
ESG
전체
Environment
Social
Governance
Event
전체
Exhibitions
Conferences
People
K-Culture
전체
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
전체
Editorials
Contributions
Who's Who
전체메뉴닫기